ACC

This channel contains news about the American College of Cardiology (ACC), including coverage of its annual meeting and links to recently released practice guidelines. The ACC is a leading resource for cardiology professionals, including all its subspecialties. 

HeartHero Personal Automated External Defibrillator Wins ACC.19 Innovation Challenge
News | Defibrillator Monitors | April 05, 2019

April 5, 2019 — Medical device startup HeartHero was the winner in the Innovation Challenge at the...

 Evolut Low Risk Trial compared the minimally invasive Evolut transcatheter aortic valve replacement (TAVR) system to the gold standard of open-heart surgery in characteristically younger, healthier aortic stenosis patients. The randomized trial, which met its primary non-inferiority endpoint of all-cause mortality or disabling stroke at two years compared to surgery (5.3 vs. 6.7 percent; posterior probability of non-inferiority >0.999), was presented at the American College of Cardiology (ACC) 2019 meeting
News | Heart Valve Technology | April 03, 2019

April 3, 2019 – The ACC.19 late-breaking landmark Evolut Low Risk Trial compared the minimally invasive Evolut...

Diabetes Drug Effective Against Heart Failure in Wide Spectrum of Patients
News | Heart Failure | March 29, 2019

March 29, 2019 — The cardiovascular benefits of the diabetes...

Vascepa Markedly Reduces First, Repeat and Total Cardiovascular Events
News | Pharmaceuticals | March 29, 2019

March 29, 2019 — Taking a high dose of icosapent ethyl significantly reduces the occurrence of first, subsequent and...

New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril/valsartan (Entresto) continued to deliver reductions in the heart failure biomarker N-terminal pro–B-type natriuretic peptide (NT-proBNP), an established biomarker for heart failure severity and prognosis.[1] The data was presented as a late-breaker at the American College of Cardiology (ACC) 2019 Annual Scientific Session in March.
News | Heart Failure | March 27, 2019

March 27, 2019 —New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril/...

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions. FFR in the cath lab.

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions.

Feature | ACC | March 27, 2019 | Greg Freiherr, Contributing Editor
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the...
Medical video game company Level Ex expanded into cardiology with the launch of Cardio Ex. It offers clinical video game scenarios that aid in cognitive, spatial-reasoning and decision-making skills in the cath lab. Medical video game app for cardiology training.

Medical video game company Level Ex expanded into cardiology with the launch of Cardio Ex. It offers clinical video game scenarios that aid in cognitive, spatial-reasoning and decision-making skills in the cath lab. 

Technology | Cardiovascular Education | March 26, 2019

March 26, 2019 — Level Ex, creators of medical video games for physicians, expanded into cardiology with the launch...

Stopping DAPT After One Month Improved Outcomes in Stent Patients
News | Antiplatelet and Anticoagulation Therapies | March 25, 2019

March 25, 2019 — Patients who stopped taking aspirin one month after...

Bempedoic Acid Combination Tablet Significantly Lowers LDL-Cholesterol

Image courtesy of Esperion

News | Pharmaceuticals | March 25, 2019

March 25, 2019 — Phase 3 results from Study 2, also known as CLEAR WISDOM, of bempedoic acid were recently presented...

HeartMate 3 Pump Shows Superior Outcomes in Advanced Heart Failure
News | Ventricular Assist Devices (VAD) | March 22, 2019

March 22, 2019 — Severely ill patients with advanced...

TAVR Outperforms Surgery in Younger, Low-Risk Aortic Stenosis Patients
News | Heart Valve Technology | March 22, 2019

March 22, 2019 — Among patients with severe symptomatic aortic stenosis at low surgical risk,...

Overlay Init